美国私立、公立及替代场所接种人乳头瘤病毒(HPV)疫苗的趋势及相关因素
该横断面分析利用2014至2020年国家青少年免疫调查数据(n=74,645),描述私立、公立及替代场所HPV疫苗接种趋势及相关因素。2014至2018年私立机构接种率年增5.3%(95%CI 3.4,7.1),2018至2020年增6.7%(95%CI 1.4,12.3)。贫困线以下青少年在公立机构接种的比值比高于私立机构(aOR=1.82,95%CI 1.60,2.08)。
要点
- 2014至2018年私立机构HPV疫苗接种年增5.3%,2018至2020年增6.7%。
- 贫困线以下青少年公立vs私立机构接种比值比aOR=1.82(95%CI 1.60,2.08)。
- 无医生推荐者公立vs私立机构接种比值比aOR=1.75(95%CI 1.44,2.12)。
核心结论
- 种族、贫困水平及是否获得医生HPV推荐与在私立机构vs公立卫生机构和替代场所接种疫苗相关。
- 作者认为该信息对于加强替代场所HPV疫苗接种以提高弱势个体疫苗可及性很重要。
研究设计与样本
- 横断面分析,利用2014至2020年国家青少年免疫调查数据(n=74,645)。
- 计算2014至2020年年变化百分比(APC),使用多项逻辑回归估计在公立卫生机构和其他替代场所vs私立医疗机构接种HPV疫苗的比值比,并调整社会人口学协变量。
主要发现
- 2014至2018年私立机构使用年增5.3%(APC=5.3;95%CI 3.4,7.1),2018至2020年增6.7%(APC=6.7;95%CI 1.4,12.3)。
- 贫困线以下青少年在公立机构vs私立机构接种的比值比aOR=1.82(95%CI 1.60,2.08),高于贫困线以上者。
- 无医生推荐青少年在公立机构vs私立机构接种的比值比aOR=1.75(95%CI 1.44,2.12),低于有推荐者。
- 白人青少年在公立机构vs私立机构接种HPV疫苗的比值比aOR=0.67(95%CI 0.57,0.78),较黑人青少年降低33%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One of the goals of the President's Cancer Panel was to maximize access to human papillomavirus (HPV) vaccination through expansion of alternative settings for receiving the vaccine, such as in public health settings, schools, and pharmacies. METHODS: In a cross-sectional analysis, we utilized the National Immunization Survey-Teen data from 2014 to 2020 (n = 74,645) to describe trends and factors associated with HPV vaccine uptake in private, public, and alternative settings. We calculated annual percent change (APC) between 2014 and 2020, estimating rate of HPV vaccine uptake across settings. Using multinomial logistic regression, we estimated the odds of receipt of HPV vaccine in public health settings and other alternative settings compared to private healthcare settings, adjusting for sociodemographic covariates. RESULTS: We found a 5 % annual increase in the use of private facilities between 2014-2018 (APC = 5.3; 95 % CI 3.4, 7.1), and almost 7 % between 2018-2020 (APC = 6.7; 95 % CI 1.4, 12.3). Adjusted multinomial logistic regression analyses found that odds of receiving vaccinations at a public facility vs. a private facility increased almost two times for adolescents living below poverty (aOR = 1.82, 95 % CI: 1.60, 2.08) compared to above poverty. Additionally, adolescents without physician recommendations had lower odds of receiving vaccines at public versus private facilities (aOR = 1.75, 95 % CI: 1.44, 2.12). Finally, odds of receiving HPV vaccines at public facilities vs. private facilities decreased by 33 % for White adolescents (aOR = 0.67, 95 % CI: 0.57, 0.78) versus Black adolescents. CONCLUSIONS: Sociodemographic factors such as race, and socioeconomic factors such as poverty level, and receipt of physician HPV recommendations are associated with receiving the vaccine at private settings vs. public health facilities and alternative settings. This information is important in strengthening alternative settings for HPV vaccine uptake to increase access to the vaccine among disadvantaged individuals.
引用
- White MC, Osazuwa-Peters OL, Abouelella DK, et al. Trends and factors associated with receipt of human papillomavirus (HPV) vaccine in private, public, and alternative settings in the United States. Vaccine. 2024. PMID: 38876838. doi:10.1016/j.vaccine.2024.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。